Charles Jabour, Arnaud Bletterer, Thierry Passeron
{"title":"标准化紫外图像半自动分析对白癜风目标区域的客观评价。","authors":"Charles Jabour, Arnaud Bletterer, Thierry Passeron","doi":"10.1001/jamadermatol.2025.2740","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>The Target Vitiligo Area Scoring Index (Target-VASI) is the primary tool for evaluating localized vitiligo lesions; however, its uncalibrated estimation in clinical practice is limited by intrarater and interrater variability. While objective methods using tracing papers or imaging systems are available, these approaches are often tedious and rely on images that are not well contrasted.</p><p><strong>Objective: </strong>To assess the reliability and the performance of a semiautomatic analysis of the lesions performed on standardized UV reflectance pictures.</p><p><strong>Design, setting, and participants: </strong>This validation study was part of a prospective, double-blind, randomized, placebo-controlled clinical trial conducted between September 2023 and February 2024 at a tertiary care center to evaluate a grafting-based therapy in difficult-to-treat vitiligo lesions. Participants included adult patients with a pair of stable vitiligo target lesions with surface areas between 2 cm2 and 20 cm2. Target-VASI was measured prior to treatment and 12 weeks after treatment by using 3 methods: the image-based system (UV image Target-VASI), tracing paper outlines (tracing paper Target-VASI), and assessments by an experienced clinician (clinician Target-VASI). The image-based system involved semiautomatic analysis of standardized UV reflectance images.</p><p><strong>Main outcomes and measures: </strong>The Target-VASI estimation methods were compared for correlation, agreement, and repeatability, with relationships scored as weak, moderate, good/strong, and very good/very strong based on results.</p><p><strong>Results: </strong>A total of 20 adult patients with a pair of stable vitiligo target lesions of surface area between 2 cm2 and 20 cm2 were enrolled. One was lost to follow-up, resulting in 19 evaluable participants included for the analysis. The mean (SD) age was 51.7 (10.7) years, and 12 (63.8%) were female. The mean (SD) vitiligo duration was 21.2 (14.4) years. A total of 61 tracing paper Target-VASIs and 76 UV image and clinician Target-VASIs were available for analysis. UV image Target-VASIs demonstrated strong correlations with tracing paper (r = 0.81 [95% CI, 0.71-0.89]; P < .001) and clinician (r = 0.89 [95% CI, 0.83-0.93]; P < .001) Target-VASIs. The agreement was also good, with mean (SD) biases of 0.81 (0.99) and 0.52 (0.76) for tracing paper and clinician Target-VASIs, respectively. Additionally, an intraclass correlation coefficient of 0.79 (95% CI, 0.60-0.88) indicated moderate to good reproducibility of Target-VASI measurements. Although errors, such as nonmatching lesion regions and oversegmented pigmentation, were identified, the overall UV image Target-VASI accuracy was largely maintained due to the precise detection of depigmented areas.</p><p><strong>Conclusions and relevance: </strong>In this investigation, the image-based system demonstrated reliable performance, suggesting its possible use in studies or routine clinical practice as a more efficient alternative to conventional approaches.</p>","PeriodicalId":14734,"journal":{"name":"JAMA dermatology","volume":" ","pages":""},"PeriodicalIF":11.0000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12444645/pdf/","citationCount":"0","resultStr":"{\"title\":\"Objective Assessment of Target Vitiligo Areas by Semiautomatic Analysis of Standardized UV Images.\",\"authors\":\"Charles Jabour, Arnaud Bletterer, Thierry Passeron\",\"doi\":\"10.1001/jamadermatol.2025.2740\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Importance: </strong>The Target Vitiligo Area Scoring Index (Target-VASI) is the primary tool for evaluating localized vitiligo lesions; however, its uncalibrated estimation in clinical practice is limited by intrarater and interrater variability. While objective methods using tracing papers or imaging systems are available, these approaches are often tedious and rely on images that are not well contrasted.</p><p><strong>Objective: </strong>To assess the reliability and the performance of a semiautomatic analysis of the lesions performed on standardized UV reflectance pictures.</p><p><strong>Design, setting, and participants: </strong>This validation study was part of a prospective, double-blind, randomized, placebo-controlled clinical trial conducted between September 2023 and February 2024 at a tertiary care center to evaluate a grafting-based therapy in difficult-to-treat vitiligo lesions. Participants included adult patients with a pair of stable vitiligo target lesions with surface areas between 2 cm2 and 20 cm2. Target-VASI was measured prior to treatment and 12 weeks after treatment by using 3 methods: the image-based system (UV image Target-VASI), tracing paper outlines (tracing paper Target-VASI), and assessments by an experienced clinician (clinician Target-VASI). The image-based system involved semiautomatic analysis of standardized UV reflectance images.</p><p><strong>Main outcomes and measures: </strong>The Target-VASI estimation methods were compared for correlation, agreement, and repeatability, with relationships scored as weak, moderate, good/strong, and very good/very strong based on results.</p><p><strong>Results: </strong>A total of 20 adult patients with a pair of stable vitiligo target lesions of surface area between 2 cm2 and 20 cm2 were enrolled. One was lost to follow-up, resulting in 19 evaluable participants included for the analysis. The mean (SD) age was 51.7 (10.7) years, and 12 (63.8%) were female. The mean (SD) vitiligo duration was 21.2 (14.4) years. A total of 61 tracing paper Target-VASIs and 76 UV image and clinician Target-VASIs were available for analysis. UV image Target-VASIs demonstrated strong correlations with tracing paper (r = 0.81 [95% CI, 0.71-0.89]; P < .001) and clinician (r = 0.89 [95% CI, 0.83-0.93]; P < .001) Target-VASIs. The agreement was also good, with mean (SD) biases of 0.81 (0.99) and 0.52 (0.76) for tracing paper and clinician Target-VASIs, respectively. Additionally, an intraclass correlation coefficient of 0.79 (95% CI, 0.60-0.88) indicated moderate to good reproducibility of Target-VASI measurements. Although errors, such as nonmatching lesion regions and oversegmented pigmentation, were identified, the overall UV image Target-VASI accuracy was largely maintained due to the precise detection of depigmented areas.</p><p><strong>Conclusions and relevance: </strong>In this investigation, the image-based system demonstrated reliable performance, suggesting its possible use in studies or routine clinical practice as a more efficient alternative to conventional approaches.</p>\",\"PeriodicalId\":14734,\"journal\":{\"name\":\"JAMA dermatology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":11.0000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12444645/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA dermatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1001/jamadermatol.2025.2740\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamadermatol.2025.2740","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
Objective Assessment of Target Vitiligo Areas by Semiautomatic Analysis of Standardized UV Images.
Importance: The Target Vitiligo Area Scoring Index (Target-VASI) is the primary tool for evaluating localized vitiligo lesions; however, its uncalibrated estimation in clinical practice is limited by intrarater and interrater variability. While objective methods using tracing papers or imaging systems are available, these approaches are often tedious and rely on images that are not well contrasted.
Objective: To assess the reliability and the performance of a semiautomatic analysis of the lesions performed on standardized UV reflectance pictures.
Design, setting, and participants: This validation study was part of a prospective, double-blind, randomized, placebo-controlled clinical trial conducted between September 2023 and February 2024 at a tertiary care center to evaluate a grafting-based therapy in difficult-to-treat vitiligo lesions. Participants included adult patients with a pair of stable vitiligo target lesions with surface areas between 2 cm2 and 20 cm2. Target-VASI was measured prior to treatment and 12 weeks after treatment by using 3 methods: the image-based system (UV image Target-VASI), tracing paper outlines (tracing paper Target-VASI), and assessments by an experienced clinician (clinician Target-VASI). The image-based system involved semiautomatic analysis of standardized UV reflectance images.
Main outcomes and measures: The Target-VASI estimation methods were compared for correlation, agreement, and repeatability, with relationships scored as weak, moderate, good/strong, and very good/very strong based on results.
Results: A total of 20 adult patients with a pair of stable vitiligo target lesions of surface area between 2 cm2 and 20 cm2 were enrolled. One was lost to follow-up, resulting in 19 evaluable participants included for the analysis. The mean (SD) age was 51.7 (10.7) years, and 12 (63.8%) were female. The mean (SD) vitiligo duration was 21.2 (14.4) years. A total of 61 tracing paper Target-VASIs and 76 UV image and clinician Target-VASIs were available for analysis. UV image Target-VASIs demonstrated strong correlations with tracing paper (r = 0.81 [95% CI, 0.71-0.89]; P < .001) and clinician (r = 0.89 [95% CI, 0.83-0.93]; P < .001) Target-VASIs. The agreement was also good, with mean (SD) biases of 0.81 (0.99) and 0.52 (0.76) for tracing paper and clinician Target-VASIs, respectively. Additionally, an intraclass correlation coefficient of 0.79 (95% CI, 0.60-0.88) indicated moderate to good reproducibility of Target-VASI measurements. Although errors, such as nonmatching lesion regions and oversegmented pigmentation, were identified, the overall UV image Target-VASI accuracy was largely maintained due to the precise detection of depigmented areas.
Conclusions and relevance: In this investigation, the image-based system demonstrated reliable performance, suggesting its possible use in studies or routine clinical practice as a more efficient alternative to conventional approaches.
期刊介绍:
JAMA Dermatology is an international peer-reviewed journal that has been in continuous publication since 1882. It began publication by the American Medical Association in 1920 as Archives of Dermatology and Syphilology. The journal publishes material that helps in the development and testing of the effectiveness of diagnosis and treatment in medical and surgical dermatology, pediatric and geriatric dermatology, and oncologic and aesthetic dermatologic surgery.
JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. It is published online weekly, every Wednesday, and in 12 print/online issues a year. The mission of the journal is to elevate the art and science of health and diseases of skin, hair, nails, and mucous membranes, and their treatment, with the aim of enabling dermatologists to deliver evidence-based, high-value medical and surgical dermatologic care.
The journal publishes a broad range of innovative studies and trials that shift research and clinical practice paradigms, expand the understanding of the burden of dermatologic diseases and key outcomes, improve the practice of dermatology, and ensure equitable care to all patients. It also features research and opinion examining ethical, moral, socioeconomic, educational, and political issues relevant to dermatologists, aiming to enable ongoing improvement to the workforce, scope of practice, and the training of future dermatologists.
JAMA Dermatology aims to be a leader in developing initiatives to improve diversity, equity, and inclusion within the specialty and within dermatology medical publishing.